NKTR
Nektar Therapeutics · Healthcare
SVP and Chief Scientific Officer Stephen K Doberstein bought $259K of Nektar Therapeutics
Bought$259,200
$17.28Price
15,000Shares
+16%Stake
What NKTR did for a copier
Prices for NKTR after this filing aren't in yet.
Stephen K Doberstein's record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Thu, Sep 5. Filed Mon, Sep 9, 1:09 PM ET, during the session. Not investment advice.